Promethera Biosciences Competitors and Similar CompaniesClear all

Intercept Pharmaceuticals's competitors and similar companies include Poxel and Gilead Sciences.

	Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases.	Poxel Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases.	Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Founding Date	Founding Date 2002	Founding Date 2009	Founding Date 1987
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare Technology	Tags Manufacturing & Industrial biotech clinical research drug development pharma
Locations	Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more	Locations Lyon, FR HQ Chiyoda City, JP Cambridge, US	Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more
Employees	Employees 58321% increase	Employees 6	Employees 18,0006% increase
Valuation ($)	Valuation ($) 794.7 m	Valuation ($) 18.3 m	Valuation ($) 110.5 b
Financial
Revenue (est.)	Revenue (est.) $285.7m (FY, 2022)	Revenue (est.) €6.6m (FY, 2024)	Revenue (est.) $29.4b (FY, 2025)
Cost of goods	Cost of goods $984k (FY, 2022)	Cost of goods €2.8m (FY, 2024)	Cost of goods $6.2b (FY, 2025)
Gross profit	Gross profit $284.7m (FY, 2022)	Gross profit €3.8m (FY, 2024)	Gross profit $23.2b (FY, 2025)
Net income	Net income $221.8m (FY, 2022)	Net income (€18.3m) (FY, 2024)	Net income $8.5b (FY, 2025)
Funding
Total funding raised	Total funding raised $ 55m	Total funding raised $ 33.8m	Total funding raised N/A